Teva Says Pivot to Growth Gains Steam as Branded Drugs, Biosimilars Outperform

Summary

Teva Pharmaceutical reports that its strategic pivot to growth is gaining momentum with branded drugs and biosimilars performing well. The company highlights outperformance in these key product categories as part of its business transformation.